Leung N - Search Results

1

Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL).

Tandon N, Sidana S, Dispenzieri A, Gertz MA, Lacy MQ, Dingli D, Buadi FK, Fonder AL, Hayman SR, Hwa YL, Hobbs MA, Kapoor P, Gonsalves WI, Leung N, Go RS, Lust JA, Russell SJ, Kyle RA, Rajkumar SV, Kumar SK. Tandon N, et al. Among authors: leung n. Am J Hematol. 2018 Jan;93(1):17-22. doi: 10.1002/ajh.24919. Epub 2017 Oct 20. Am J Hematol. 2018. PMID: 28960427 Free article.

2

Long-term outcome of renal transplantation in light-chain deposition disease.

Leung N, Lager DJ, Gertz MA, Wilson K, Kanakiriya S, Fervenza FC. Leung N, et al. Am J Kidney Dis. 2004 Jan;43(1):147-53. doi: 10.1053/j.ajkd.2003.09.020. Am J Kidney Dis. 2004. PMID: 14712438

3

Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation.

Leung N, Slezak JM, Bergstralh EJ, Dispenzieri A, Lacy MQ, Wolf RC, Gertz MA. Leung N, et al. Am J Kidney Dis. 2005 Jan;45(1):102-11. doi: 10.1053/j.ajkd.2004.09.015. Am J Kidney Dis. 2005. PMID: 15696449

4

Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement.

Leung N, Griffin MD, Dispenzieri A, Haugen EN, Gloor JM, Schwab TR, Textor SC, Lacy MQ, Litzow MR, Cosio FG, Larson TS, Gertz MA, Stegall MD. Leung N, et al. Am J Transplant. 2005 Jul;5(7):1660-70. doi: 10.1111/j.1600-6143.2005.00920.x. Am J Transplant. 2005. PMID: 15943624 Free article.

5

Excessive fluid accumulation during stem cell mobilization: a novel prognostic factor of first-year survival after stem cell transplantation in AL amyloidosis patients.

Leung N, Leung TR, Cha SS, Dispenzieri A, Lacy MQ, Gertz MA. Leung N, et al. Among authors: leung tr. Blood. 2005 Nov 15;106(10):3353-7. doi: 10.1182/blood-2005-03-1206. Epub 2005 Jul 21. Blood. 2005. PMID: 16037390 Free article. Clinical Trial.

6

Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis.

Leung N, Dispenzieri A, Fervenza FC, Lacy MQ, Villicana R, Cavalcante JL, Gertz MA. Leung N, et al. Am J Kidney Dis. 2005 Aug;46(2):270-7. doi: 10.1053/j.ajkd.2005.05.010. Am J Kidney Dis. 2005. PMID: 16112045 Review.

7

Myeloablative chemotherapy and stem cell transplantation in myeloma or primary amyloidosis with renal involvement.

Gertz MA, Leung N, Lacy MQ, Dispenzieri A. Gertz MA, et al. Among authors: leung n. Kidney Int. 2005 Oct;68(4):1464-71. doi: 10.1111/j.1523-1755.2005.00559.x. Kidney Int. 2005. PMID: 16164623 Free article. Review.

8

Treatment of diuretic refractory pleural effusions with bevacizumab in four patients with primary systemic amyloidosis.

Hoyer RJ, Leung N, Witzig TE, Lacy MQ. Hoyer RJ, et al. Among authors: leung n. Am J Hematol. 2007 May;82(5):409-13. doi: 10.1002/ajh.20858. Am J Hematol. 2007. PMID: 17326106 Free article.

9

Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myeloma.

Gertz MA, Lacy MQ, Dispenzieri A, Hayman SR, Kumar S, Leung N, Gastineau DA. Gertz MA, et al. Among authors: leung n. Bone Marrow Transplant. 2007 May;39(10):605-11. doi: 10.1038/sj.bmt.1705627. Epub 2007 Mar 19. Bone Marrow Transplant. 2007. PMID: 17369867

10

Renal manifestations of plasma cell disorders.

Leung N, Rajkumar SV. Leung N, et al. Am J Kidney Dis. 2007 Jul;50(1):155-65. doi: 10.1053/j.ajkd.2007.05.007. Am J Kidney Dis. 2007. PMID: 17591537 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,031 results

Search Page

Filters